IRISH THORACIC SOCIETY LUNG CANCER SYMPOSIUM
For gallery of event click here
Lung Cancer and the National Cancer Control Programme
Professor Tom Keane, Interim Director, National Cancer Control
Programme
New Bronchoscopic Developments in the Diagnosis and Staging of Lung
Cancer
Dr Robert Rintoul, Consultant Respiratory Physician, Lead Clinician Thoracic Oncology,
Papworth Hospital, Cambridge
The Road to a New TNM-classification for Lung Cancer
Professor Jan P. Van Meerbeeck, MD, PhD, Professor of Thoracic Oncology University of
Ghent,
Divisional Head, University Hospital Ghent, Belgium
Professor Tom Keane MB, BCh, MRCPI, FRCPC, FFRRCSI (Hon)
Prof. Tom Keane was raised in Sandycove in south Co. Dublin and is a graduate of University College Dublin. He completed three years' postgraduate training at St Vincent's Hospital and the Adelaide Hospital in Dublin, before leaving Ireland to train in Radiation Oncology at the Princess Margaret Hospital in Toronto. He was appointed as a Consultant Radiation Oncologist in 1978.
In 1995 he took up the position of Provincial Radiation Therapy Programme Leader in the British Columbia Cancer Agency in Vancouver, where he was also Head of the Division of Radiation Oncology and Developmental Radiotherapeutics at the University of British Columbia.
His areas of expertise include radiation oncology (head and neck, gastrointestinal cancer), RT program planning, health care leadership and process management.
He was a key figure in the overhaul of cancer services in British Columbia & has been drafted in by the HSE on a two year secondment to implement the National Cancer Control Strategy and transform the provision of oncology services in Ireland.
Dr Robert Rintoul, Consultant Respiratory Physician, Lead Clinician Thoracic Oncology
Papworth Hospital, Cambridge
Robert Rintoul is a consultant respiratory physician with a special interest in lung cancer and mesothelioma at Papworth Hospital, Cambridge, UK. He undertook clinical training in Edinburgh and London and performed his doctoral research in Professor Tariq Sethi’s laboratory in the University of Edinburgh.
He is currently lead clinician for cancer at Papworth Hospital and has a particular interest in the staging of the mediastinum. He has piloted the development of endobronchial ultrasound both in Edinburgh and Cambridge. Currently he is a principal investigator for several translational research studies in lung cancer.
Dr. Van Meerbeeck, MD, PhD Professor of Thoracic Oncology University of Ghent, Divisional Head, University Hospital Ghent, Belgium
Dr. Van Meerbeeck, MD, PhD is a board certified chest physician, professor in Thoracic Oncology at Ghent University and chair of the Thoracic Oncology Programme at the University Hospital Ghent. His scientific interests are the molecular diagnosis, minimally invasive staging and multimodality treatment of mesothelioma and lung cancer. He is and has been the study coordinator and principal investigator for numerous international phase 2 and 3 studies.
He has served the EORTC Lung Cancer Group as secretary from 1994-2000, chairman from 2003-2006, past chair and General Assembly member since. He is member of the IASLC staging committee and several other national and scientific organisations (ESMO, ASCO, IMIG, …). He has been (co-)promotor of several PhD’s in Belgium and the Netherlands. He has published more than 100 peer-reviewed articles in oncology and pulmonology journals and textbooks. He is on the review and editorial board of several international journals. He has (co-)organized several national and international scientific meetings on thoracic oncology. He is grant reviewer for the Flemish Foundation of Scientific Research (FWO) and the Dutch Cancer Foundation (KWF).
